Skip to main content

Jessica Hagen

By Jessica Hagen | 03:04 pm | October 26, 2022
The health insurer's members will receive free home delivery for common medications through Amazon Pharmacy.
By Jessica Hagen | 11:26 am | October 26, 2022
Consumers can use the tests to detect Lyme disease, vitamin D levels, thyroid function and sexually transmitted infections.
By Jessica Hagen | 03:29 pm | October 25, 2022
Noala, Elion and Upheal also announced funding rounds.
By Jessica Hagen | 02:21 pm | October 24, 2022
The company will speed up its clinical trial recruitment measures, raise awareness of post-approval treatments and support cancer research.
By Jessica Hagen | 01:39 pm | October 24, 2022
The acquisition will expand Unified's portfolio of women-focused companies to include menopause-relief offerings in all 50 states.
By Jessica Hagen | 12:56 pm | October 21, 2022
When determining approval for Breakthrough Device designation, the FDA will consider whether the device addresses present health inequities.
By Jessica Hagen | 03:22 pm | October 20, 2022
The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer's patients.
By Jessica Hagen | 11:21 am | October 20, 2022
A study published in JAMA Network Open found that increased EHR use among primary care physicians was associated with improved patient A1c levels, hypertension control and breast cancer screening rates.
By Jessica Hagen | 03:04 pm | October 19, 2022
The multinational pharma company will now be able to access Tempus' de-identified patient data.
By Jessica Hagen | 05:13 pm | October 18, 2022
The newest offering is spirometry testing to evaluate patients for chronic obstructive pulmonary disease.